KARD

Conviction 0HealthcareScan · Fri, Jul 17, 2026

KARD$21.02-4.41%

ResistanceSupportVol 14Insider buy

Vol MA14 561.01K

Jun 18Jun 25Jun 30Jul 7Jul 10Jul 16

Kardigan, Inc.Pharmaceutical Preparations

Price21.02

Change-4.41%

Gap+0.05%

Rel volume0.44×

Avg volume839K

Avg $ vol19.28M

SMA 20—

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 29.27

RSI (14)45

MACD hist—

MACD cross—

Stoch %K / %D8 / 13

ADX (14)—

+DI / −DI15 / 14

RSI divergence—

MACD divergence—

ATR %+12.55%

ADR %—

52w high25.90

52w low21.02

From 52w high-18.84%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width—

%B—

Donchian pos—

Donchian high—

Donchian low—

AVWAP (52w high)23.83

vs AVWAP high-11.81%

AVWAP (52w low)22.45

vs AVWAP low-6.37%

OBV trend—

Chaikin MF (20)—

Today vs 20d0.44×

Avg vol (14d)561K

Avg vol (20d)839K

Avg $ vol (20d)19.28M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank19.5

1 week-14.03%

1 month—

3 months—

6 months—

1 year—

YTD-4.45%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target43.50

Target upside106.95%

Analyst ratingBuy

Institutional0.25%

Ent. value—

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryPharmaceutical Preparations

ExchangeNasdaq

Shares out—

Employees—

Listed—

Free float37.23M

Float %41.7%

Short interest1.47M

Days to cover1.4d

Short volume39.6%

Squeeze score15 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank19.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in KARD

All disclosures →

No recent disclosed trades by Congress in KARD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KARD · 6 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
PERCEPTIVE ADVISORS LLC Director · Common Stock · 2026-06-17	Grant	20.71K	—	2026-06-17	2026-07-13
BERNS PAUL L Director · Common Stock · 2026-06-22	Buy	1.25M	$20M	2026-06-22	2026-06-24
ARCH Venture Partners XIII, LLC Director · Common Stock · 2026-06-22	Buy	1.25M	$20M	2026-06-22	2026-06-24
GIANAKAKOS ANASTASIOS President & CEO · Series A Preferred Stock · 2026-06-17	Convert	25.74K	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Series B Preferred Stock · 2026-06-17	Convert	313.09K	—	2026-06-17	2026-06-22
HRTG GPE, LLC 10% owner · Series A Redeemable Convertible Preferred Stock · 2026-06-17	Convert	3.86M	—	2026-06-17	2026-06-22
BERNS PAUL L Director · Common Stock · 2026-06-17	Convert	13.79M	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Series A Preferred Stock · 2026-06-17	Convert	18.02K	—	2026-06-17	2026-06-22
Walbert Timothy P Director · Common Stock · 2026-06-17	Grant	20.71K	—	2026-06-17	2026-06-22
GIANAKAKOS ANASTASIOS President & CEO · Common Stock · 2026-06-17	Convert	28.7K	—	2026-06-17	2026-06-22

SEC filings

EDGAR filings in KARD · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.